Swiss Life Asset Management’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.54M | Buy |
23,360
+5,867
| +34% | +$1.54M | 0.03% | 411 |
|
|
2026
Q1 | $4.67M | Sell |
17,493
-1,220
| -7% | -$330K | 0.02% | 419 |
|
|
2025
Q4 | $4.69M | Sell |
18,713
-18,316
| -49% | -$4.86M | 0.02% | 419 |
|
|
2025
Q3 | $10.6M | Buy |
37,029
+20,276
| +121% | +$5.43M | 0.06% | 260 |
|
|
2025
Q2 | $4.4M | Sell |
16,753
-19,650
| -54% | -$4.78M | 0.03% | 404 |
|
|
2025
Q1 | $8.47M | Buy |
36,403
+23,144
| +175% | +$5.62M | 0.06% | 235 |
|
|
2024
Q4 | $3.04M | Buy |
13,259
+9,969
| +303% | +$2.29M | 0.02% | 403 |
|
|
2024
Q3 | $734K | Sell |
3,290
-207
| -6% | -$45.5K | 0.01% | 482 |
|
|
2024
Q2 | $712K | Buy |
+3,497
| New | +$711K | 0.01% | 460 |
|
|
2024
Q1 | – | Sell |
-5,484
| Closed | -$1.25M | – | 588 |
|
|
2023
Q4 | $1.25M | Sell |
5,484
-2,561
| -32% | -$538K | 0.02% | 471 |
|
|
2023
Q3 | $1.62M | Sell |
8,045
-10,700
| -57% | -$2.26M | 0.03% | 521 |
|
|
2023
Q2 | $3.89M | Sell |
18,745
-3,889
| -17% | -$754K | 0.06% | 375 |
|
|
2023
Q1 | $4.46M | Sell |
22,634
-3,624
| -14% | -$746K | 0.07% | 339 |
|
|
2022
Q4 | $5.33M | Sell |
26,258
-13,912
| -35% | -$2.72M | 0.09% | 258 |
|
|
2022
Q3 | $7.07M | Buy |
40,170
+15,951
| +66% | +$3.27M | 0.12% | 199 |
|
|
2022
Q2 | $4.89M | Sell |
24,219
-2,609
| -10% | -$556K | 0.08% | 274 |
|
|
2022
Q1 | $6.07M | Sell |
26,828
-11,878
| -31% | -$2.79M | 0.09% | 250 |
|
|
2021
Q4 | $10.4M | Buy |
38,706
+7,784
| +25% | +$1.93M | 0.14% | 177 |
|
|
2021
Q3 | $7.47M | Buy |
30,922
+5,574
| +22% | +$1.4M | 0.1% | 229 |
|
|
2021
Q2 | $6.91M | Sell |
25,348
-17,601
| -41% | -$4.01M | 0.07% | 265 |
|
|
2021
Q1 | $9.41M | Buy |
42,949
+1,367
| +3% | +$274K | 0.13% | 195 |
|
|
2020
Q4 | $7.27M | Buy |
41,582
+20,188
| +94% | +$3.49M | 0.11% | 224 |
|
|
2020
Q3 | $3.45M | Buy |
21,394
+1,696
| +9% | +$269K | 0.05% | 246 |
|
|
2020
Q2 | $2.81M | Sell |
19,698
-6,271
| -24% | -$868K | 0.05% | 265 |
|
|
2020
Q1 | $2.82M | Buy |
25,969
+2,546
| +11% | +$367K | 0.05% | 225 |
|
|
2019
Q4 | $3.41M | Buy |
23,423
+4,386
| +23% | +$633K | 0.06% | 233 |
|
|
2019
Q3 | $2.75M | Buy |
19,037
+1,705
| +10% | +$249K | 0.04% | 282 |
|
|
2019
Q2 | $2.57M | Buy |
17,332
+1,950
| +13% | +$272K | 0.03% | 275 |
|
|
2019
Q1 | $2.02M | Buy |
+15,382
| New | +$1.89M | 0.03% | 291 |
|
|
2018
Q4 | – | Sell |
-20,394
| Closed | -$3.04M | – | 346 |
|
|
2018
Q3 | $3.04M | Buy |
20,394
+15,761
| +340% | +$2.4M | 0.04% | 246 |
|
|
2018
Q2 | $715K | Sell |
4,633
-12,039
| -72% | -$1.82M | 0.01% | 403 |
|
|
2018
Q1 | $2.32M | Sell |
16,672
-1,099
| -6% | -$161K | 0.04% | 272 |
|
|
2017
Q4 | $2.44M | Buy |
17,771
+11,724
| +194% | +$1.55M | 0.05% | 193 |
|
|
2017
Q3 | $784K | Sell |
6,047
-4,652
| -43% | -$620K | 0.02% | 340 |
|
|
2017
Q2 | $1.41M | Sell |
10,699
-6,043
| -36% | -$740K | 0.04% | 239 |
|
|
2017
Q1 | $2.06M | Buy |
+16,742
| New | +$1.98M | 0.06% | 181 |
|
|
2016
Q2 | – | Sell |
-4,414
| Closed | -$444K | – | 352 |
|
|
2016
Q1 | $444K | Sell |
4,414
-3,044
| -41% | -$292K | 0.02% | 282 |
|
|
2015
Q4 | $792K | Buy |
7,458
+3,571
| +92% | +$368K | 0.04% | 179 |
|
|
2015
Q3 | $362K | Sell |
3,887
-13,537
| -78% | -$1.4M | 0.02% | 245 |
|
|
2015
Q2 | $1.81M | Buy |
17,424
+13,887
| +393% | +$1.45M | 0.06% | 123 |
|
|
2015
Q1 | $383K | Buy |
+3,537
| New | +$364K | 0.02% | 192 |
|
Other funds holding LH
Swiss Life Asset Management's LH Position: Q2 2026 in Review
Swiss Life Asset Management increased its Labcorp (LH) stake by 34% in Q2 2026, buying an estimated $1.54M and bringing the position to 23,360 shares worth $6.54M. The position accounts for 0.03% of the portfolio, ranked #411.
Swiss Life Asset Management first reported a position in LH in Q1 2015 and has held it in 41 quarters since. The position peaked at $10.6M in Q3 2025. 751 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Swiss Life Asset Management held 23,360 shares of Labcorp worth $6.54M as of Q2 2026.
- Swiss Life Asset Management bought 5,867 Labcorp shares in Q2 2026, an estimated $1.54M.
- Labcorp made up 0.03% of Swiss Life Asset Management's portfolio in Q2 2026, its #411 holding.
- Swiss Life Asset Management first reported a position in Labcorp in Q1 2015 and has held it in 41 quarters since.
- Swiss Life Asset Management's Labcorp position peaked at $10.6M in Q3 2025.
- 751 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.